Artelo biosciences to present at the winter wrap-up microcap rodeo conference on february 20th

Solana beach, ca / accesswire / february 15, 2024 / artelo biosciences, inc. (nasdaq:artl), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be participating in the winter wrap-up microcap rodeo conference, which will be held virtually tuesday, february 20th through friday, february 23rd, 2024. gregory d.
ARTL Ratings Summary
ARTL Quant Ranking